Canada – Researchers have designed a prototype Chlamydia vaccine, tested in mice, with the first results suggesting that the virus could be terminated in the next few years.
The research was published in the journal Vaccine, where it shows hat mice given then vaccine are more likely to battle Chlamydia than the ones’ who haven’t received any particular form of treatment.
It is worth adding that no vaccine is approved for human use against Chlamydia, which is the second most common sexually transmitted disease after AIDS.
CDC’s report on Chlamydia states that approximately 2.86 million cases of infections are being reported within U.S. borders every year.
The research took place at McMaster University in Ontario, where researchers gave mice two doses of the prototype vaccine, delivered through the nose.
When the mice were later exposed to Chlamydia, the ones who received the vaccine showed fewer copies of the bacteria replicating in their system, while they also had fewer signs of damage to their reproductive organs.
Dr. David Bulir, a member of the researching team, told local media about the study’s results.
“Vaccination would be the best way to way to prevent a chlamydia infection, and this study has identified important new antigens which could be used as part of a vaccine to prevent or eliminate the damaging reproductive consequences of untreated infections.“
Professor James Mahony also added, “We will trial the vaccine on other animal models before moving on to human trials. The results are very promising.”
Moreover, researchers hope that their vaccine will be effective against Chlamydia infections of the eye, which is a common cause of blindness in developing countries in Africa and Asia.
At the moment, the sole way for one to protect himself from contracting the disease is to use a condom while having sexual coitus.
On a less relevant note, Public Health England in their report urged any individual aged under 25 who is sexually active to be tested for Chlamydia every year and when they shift partners.
Chlamydia is amongst the most common sexually transmitted diseases in the U.K. as well, with 200,000 diagnoses reported in 2015, 129,000 of which had occurred among individuals between the ages of 15 and 24 years.
Via: Medical News Today